Huntsman Ronald Kirk 4
4 · Vivos Therapeutics, Inc. · Filed Jun 28, 2024
Insider Transaction Report
Form 4
Huntsman Ronald Kirk
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2024-06-20$2.38/sh+20,000$47,600→ 49,334 totalExercise: $2.38Exp: 2029-06-20→ Common Stock (20,000 underlying)
Holdings
- 69,600(indirect: See footnote)
Common Stock
- 3,461
Common Stock
Footnotes (2)
- [F1]Shares held by Coronado V Partners, LLC, of which the Reporting Person is a member and manager.
- [F2]On June 20, 2024 (the "Grant Date"), the Reporting Person received a grant of 20,000 stock options from the Issuer. One-fifth vested immediately and one-fifth will vest annually on each anniversary of the Grant Date through June 20, 2028.